259 related articles for article (PubMed ID: 32557846)
1. Efficacy of transdermal immunotherapy with biodegradable microneedle patches in a murine asthma model.
Park KH; Oh EY; Han H; Kim JD; Kim SJ; Jeong KY; Kim JH; Park CO; Kim SR; Lee JH; Jeong DH; Yong TS; Lee KH; Park JW
Clin Exp Allergy; 2020 Sep; 50(9):1084-1092. PubMed ID: 32557846
[TBL] [Abstract][Full Text] [Related]
2. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
Hesse L; Petersen AH; Nawijn MC
Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model.
Hesse L; van Ieperen N; Habraken C; Petersen AH; Korn S; Smilda T; Goedewaagen B; Ruiters MH; van der Graaf AC; Nawijn MC
Allergy; 2018 Apr; 73(4):862-874. PubMed ID: 29318623
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
Hesse L; Nawijn MC
Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
[TBL] [Abstract][Full Text] [Related]
5. A new house dust mite-driven and mast cell-activated model of asthma in the guinea pig.
Ramos-Ramírez P; Noreby M; Liu J; Ji J; Abdillahi SM; Olsson H; Dahlén SE; Nilsson G; Adner M
Clin Exp Allergy; 2020 Oct; 50(10):1184-1195. PubMed ID: 32691918
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of Galectin-9 on allergen-specific sublingual immunotherapy in a Dermatophagoides farinae-induced mouse model of chronic asthma.
Ikeda M; Katoh S; Shimizu H; Hasegawa A; Ohashi-Doi K; Oka M
Allergol Int; 2017 Jul; 66(3):432-439. PubMed ID: 27876361
[TBL] [Abstract][Full Text] [Related]
7. Association between biomarkers and house dust mite sublingual immunotherapy in allergic asthma.
Hoshino M; Akitsu K; Kubota K; Ohtawa J
Clin Exp Allergy; 2020 Sep; 50(9):1035-1043. PubMed ID: 32557974
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous Immunotherapy for Allergic Asthma in a Single Center of Korea: Efficacy, Safety, and Clinical Response Predictors.
Lee JH; Kim SC; Choi H; Jung CG; Ban GY; Shin YS; Nahm DH; Park HS; Ye YM
J Korean Med Sci; 2017 Jul; 32(7):1124-1130. PubMed ID: 28581269
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy efficacy of Dermatophagoides farinae vaccine in a murine asthma model.
Yu HQ; Li XH; Guo H; Liu ZG; Ran PX; Ji KM; Wang J
Int Arch Allergy Immunol; 2010; 152(1):41-8. PubMed ID: 19940504
[TBL] [Abstract][Full Text] [Related]
10. Dietary galacto-oligosaccharides prevent airway eosinophilia and hyperresponsiveness in a murine house dust mite-induced asthma model.
Verheijden KA; Willemsen LE; Braber S; Leusink-Muis T; Delsing DJ; Garssen J; Kraneveld AD; Folkerts G
Respir Res; 2015 Feb; 16(1):17. PubMed ID: 25849971
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation.
Tourdot S; Airouche S; Berjont N; Da Silveira A; Mascarell L; Jacquet A; Caplier L; Langelot M; Baron-Bodo V; Moingeon P
Clin Exp Allergy; 2011 Dec; 41(12):1784-92. PubMed ID: 22092967
[TBL] [Abstract][Full Text] [Related]
12. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of allergen extracts from Dermatophagoides farinae desensitizes specific allergen-induced inflammation and airway hyperresponsiveness in rats.
Xie QM; Wu X; Wu HM; Deng YM; Zhang SJ; Zhu JP; Dong XW
Int Immunopharmacol; 2008 Dec; 8(12):1639-45. PubMed ID: 18721904
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.
Hesse L; Brouwer U; Petersen AH; Gras R; Bosman L; Brimnes J; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC
Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757
[TBL] [Abstract][Full Text] [Related]
16. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma.
Agache I; Lau S; Akdis CA; Smolinska S; Bonini M; Cavkaytar O; Flood B; Gajdanowicz P; Izuhara K; Kalayci O; Mosges R; Palomares O; Papadopoulos NG; Sokolowska M; Angier E; Fernandez-Rivas M; Pajno G; Pfaar O; Roberts GC; Ryan D; Sturm GJ; van Ree R; Varga EM; van Wijk RG; Yepes-Nuñez JJ; Jutel M
Allergy; 2019 May; 74(5):855-873. PubMed ID: 31095767
[TBL] [Abstract][Full Text] [Related]
17. House Dust Mite-Specific Sublingual Immunotherapy Prevents the Development of Allergic Inflammation in a Mouse Model of Experimental Asthma.
Hagner S; Rask C; Brimnes J; Andersen PS; Raifer H; Renz H; Garn H
Int Arch Allergy Immunol; 2016; 170(1):22-34. PubMed ID: 27287860
[TBL] [Abstract][Full Text] [Related]
18. SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma.
Blumberga G; Groes L; Dahl R
Allergy; 2011 Feb; 66(2):178-85. PubMed ID: 20883456
[TBL] [Abstract][Full Text] [Related]
19. [Immunotherapy effect of ploypeptide vaccine of allergen group 1 from Dermatophagoides farinae on asthma mice].
Song HY; Duan BB; Li CP
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2015 Oct; 27(5):490-6. PubMed ID: 26930933
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of CpG oligodeoxynucleotides on house dust mite-induced airway inflammation in mice.
Hirose I; Tanaka H; Takahashi G; Wakahara K; Tamari M; Sakamoto T; Kojima S; Inagaki N; Nagai H
Int Arch Allergy Immunol; 2008; 147(1):6-16. PubMed ID: 18446048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
